Chiara F. Fratte-Dalle
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers.
Journal: The journal of liquid biopsy
Published: January 24, 2024
Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy.
Journal: Frontiers in cardiovascular medicine
Published: January 25, 2023
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.
Journal: International journal of molecular sciences
Published: November 03, 2022
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Published: September 22, 2022
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.
Journal: British journal of clinical pharmacology
Published: June 17, 2022
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy.
Journal: Frontiers in pharmacology
Published: September 17, 2021
A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Journal: Oncology research
Published: June 10, 2021
Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib.
Journal: Frontiers in pharmacology
Published: October 11, 2019
Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes.
Journal: International journal of molecular sciences
Published: October 02, 2019
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: December 12, 2018
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice.
Journal: Clinical pharmacology and therapeutics
Published: July 06, 2018
Last Updated: 09/26/2026